Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 31 of Compass Therapeutics, Inc.'s SEC filings and found 1 warrant series, 2 ATM programs, 2 shelf registrations and 1 completed offering on file for CMPX. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 31, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
MSLESatellos Bioscience Inc.
MENSJyong Biotech Ltd. Ordinary Shares
MOLNMolecular Partners AG American Depositary Shares
NGENNervGen Pharma Corp. Common stock
TARAProtara Therapeutics, Inc.
CUECue Biopharma, Inc.
MXCTMaxCyte, Inc.
VRXAVeraxa Biotech AG Ordinary Shares
FHTXFoghorn Therapeutics Inc.
MGNXMacroGenics, Inc.
SPRBSpruce Biosciences, Inc.
CHRSCoherus Oncology, Inc.
IPHAInnate Pharma S.A. ADS
NBPNovaBridge Biosciences
HUMAHumacyte, Inc.